作者：
Singh, Dave [1]
;
Bafadhel, Mona [2]
;
Brightling, Christopher E. [3]
;
Sciurba, Frank C. [4]
;
Curtis, Jeffrey L. [5]
;
Martinez, Fernando J. [6]
;
Pasquale, Cara B. [7]
;
Merrill, Debora D. [8]
;
Metzdorf, Norbert [9]
;
Petruzzelli, Stefano [10]
;
Tal-Singer, Ruth [11]
;
Compton, Christopher [12]
;
Rennard, Stephen [13]
;
Martin, Ubaldo J.
作者单位：
COPD Fdn, COPD Patient Powered Res Network, Washington, DC USA
[1]
COPD Fdn, COPD Biomarkers Qualificat Consortium, Miami, FL USA
[2]
Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[3]
Chiesi Farmaceut, Global Clin Dev, Parma, Italy
[4]
GlaxoSmithKline, Global Med Affairs Special & Primary Care, Brentford, Middx, England
[5]
AstraZeneca, Biopharmaceut R&D, Cambridge, England
[6]
AstraZeneca, Res & Dev, Gaithersburg, MD USA
[7]
Univ Manchester, Manchester Univ Natl Hlth Serv Hosp Trust, Div Infect Immun & Resp Med, Southmoor
[8]
Univ Oxford, Nuffield Dept Med, Resp Med Unit, Oxford, England
[9]
Univ Leicester, Natl Inst Hlth Res Leicester Biomed Res Ctr, Inst Lung Hlth, Dept Resp & Infect Sci
[10]
Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA
[11]
VA Ann Arbor Healthcare Syst, Pulm & Crit Care Med, Ann Arbor, MI USA
[12]
Weill Cornell Med Coll, Pulm & Crit Care Med, New York, NY USA
[13]
发布时间
2022-10-11
换一批
